Legal Representation
Attorney
John Janeway
USPTO Deadlines
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 5, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Feb 5, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 19, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 19, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 19, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 29, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 30, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 035
Commercial advisory services to inform the evaluation process involved in decisions about potentially in-licensing or purchasing a biotech, pharmaceutical, diagnostic or device asset or potentially investing in a company with this type of asset by providing primary market research to quantify expected physician demand and inform a data-driven revenue model for that asset
First Use Anywhere:
Nov 28, 2022
First Use in Commerce:
Nov 28, 2022
Additional Information
Pseudo Mark
DUE DILIGENCE MD
Classification
International Classes
035